Dawn O’Connell, HHS' assistant secretary for preparedness and response (Michael Brochstein/Sipa USA)(Sipa via AP Images)

Op­er­a­tion Warp Speed re­dux: HHS awards $1.4B to de­vel­op next-gen Covid-19 drugs and vac­cines

HHS on Tues­day an­nounced it’s pump­ing $1.4 bil­lion in gov­ern­ment funds in­to next-gen Covid-19 med­ical prod­ucts in the pipeline, in­clud­ing $326 mil­lion to Re­gen­eron to help de­vel­op a Covid-19 mon­o­clon­al an­ti­body.

The an­nounce­ment is the first pub­lic step for­ward for Project NextGen, which aims to spend $5 bil­lion on de­vel­op­ing new Covid-19 ther­a­pies and vac­cines, the Biden ad­min­is­tra­tion an­nounced in May.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.